OPK

OPKO’s Longer-Acting Clotting Factor VIIa-CTP Receives Orphan Drug Designation in the U.S.

[Business Wire] – OPKO Health, Inc. today announced that the U.S. Food and Drug Administration has granted orphan drug designation to OPKO’s longer-acting version of clotting Factor VIIa for the treatment of bleeding episodes in patients with hemophilia moreView todays social media effects on OPKView the latest stocks trending across Twitter. Click to view dashboardSee who OPKO is hiring […]

Opko: Ignore The Commentary And Focus On Numbers

moreView todays social media effects on OPKView the latest stocks trending across Twitter. Click to view dashboardSee who OPKO is hiring next, click here to view […]

Odd strategy is bullish on Opko

moreView todays social media effects on OPKView the latest stocks trending across Twitter. Click to view dashboardSee who OPKO is hiring next, click here to view […]

9:46 am Opko Health announces successful confirmation of 4Kscore algorithm in the U.S.; results support the U.S. launch of the 4Kscore test in March 2014

moreView todays social media effects on OPKView the latest stocks trending across Twitter. Click to view dashboardSee who OPKO is hiring next, click here to view […]

OPKO Announces Successful Confirmation of 4Kscoreâ„¢ Algorithm in the United States

[Business Wire] – OPKO Health, Inc. announced the successful completion of the calibration confirmation phase of the 4Kscoreâ„¢ test clinical validation study currently underway at 21 urolo moreView todays social media effects on OPKView the latest stocks trending across Twitter. Click to view dashboardSee who OPKO is hiring next, click here to view […]